<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(5)</volume><submitter>Mu S</submitter><funding>National Natural Science Foundation of China</funding><journal>Clinical and translational medicine</journal><pagination>e754</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9076010</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>PD-L1/TIGIT bispecific antibody showed survival advantage in animal model.</pubmed_title><pmcid>PMC9076010</pmcid><funding_grant_id>81673347</funding_grant_id><funding_grant_id>81872785</funding_grant_id><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Chu W</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Liang Z</pubmed_authors><pubmed_authors>Wang G</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Chen YL</pubmed_authors><pubmed_authors>Mu S</pubmed_authors></additional><is_claimable>false</is_claimable><name>PD-L1/TIGIT bispecific antibody showed survival advantage in animal model.</name><description/><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2026-05-09T20:15:05.716Z</modification><creation>2025-02-19T00:56:25.468Z</creation></dates><accession>S-EPMC9076010</accession><cross_references><pubmed>35522941</pubmed><doi>10.1002/ctm2.754</doi></cross_references></HashMap>